SCHEMBL19082147

SCHEMBL19082147

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc5sc6c(ccc7c6sc6ccc8ccccc8c67)c5c4)c4ccccc34)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 3/20 0.38
CYP1B1 Q16678 2/20 0.38
LIMK1 P53667 2/20 0.38
F9 P00740 2/20 0.35
NQO2 P16083 2/20 0.35
NQO1 P15559 1/20 0.35
PIM3 Q86V86 2/20 0.34
PIM1 P11309 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
ESR1 P03372 3/20 0.33
ESR2 Q92731 3/20 0.33
CDK4 P11802 1/20 0.33
CCND1 P24385 1/20 0.33
CYP1A2 P05177 2/20 0.33
FYN P06241 1/20 0.33
MAPK3 P27361 1/20 0.33
AHR P35869 1/20 0.33
PAX8 Q06710 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
PTPN1 P18031 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082213 0.97 LIMK1 (0.40) CYP1A1CYP1B1LIMK1F9NQO2
SCHEMBL19082339 0.95 F9 (0.36) CYP1A1CYP1B1LIMK1F9NQO2
SCHEMBL19082289 0.92 ESR1 (0.36) CYP1A1CYP1B1LIMK1F9NQO2
SCHEMBL19082138 0.92 CYP1A1 (0.38) CYP1A1CYP1B1LIMK1F9NQO2
SCHEMBL19082139 0.92 CYP1A1 (0.44) CYP1A1CYP1B1LIMK1F9NQO2
SCHEMBL19082150 0.92 CYP1A1 (0.38) CYP1A1CYP1B1LIMK1F9NQO2
SCHEMBL19082089 0.91 CYP1A1 (0.45) CYP1A1CYP1B1LIMK1F9NQO2
SCHEMBL19082102 0.91 CYP1A1 (0.39) CYP1A1CYP1B1LIMK1F9NQO2
SCHEMBL19082086 0.91 CYP1A1 (0.39) CYP1A1CYP1B1LIMK1F9NQO2
SCHEMBL19082126 0.91 NQO2 (0.36) CYP1A1CYP1B1LIMK1F9NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885LIMK1 440/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885LIMK1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.